Innate immune recognition of, and regulation by, DNA

Trends in Immunology

Volumn 27, Issue 11, 2006, Pages 525-532

  Ishii, Ken J ^a   Akira, Shizuo ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; OLIGODEOXYNUCLEOTIDE; TOLL LIKE RECEPTOR 9;

AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CPG ISLAND; CYTOKINE PRODUCTION; DNA TRANSFER; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; IMMUNOSTIMULATION; IMMUNOTHERAPY; INNATE IMMUNITY; NONHUMAN; PROTEIN DNA BINDING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; BIOLOGICAL TRANSPORT; CPG ISLANDS; DNA; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; IMMUNITY, NATURAL; TOLL-LIKE RECEPTOR 9;

EID: 33749490571     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2006.09.002     Document Type: Review

References (85)

1. Akira S., et al. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
2. Nagata S. DNA degradation in development and programmed cell death. Annu Rev. Immunol. 23 (2005) 853-875
3. Klinman D.M. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol. 4 (2004) 249-258
4. Wagner H. The immunobiology of the TLR9 subfamily. Trends Immunol. 25 (2004) 381-386
5. Krieg A.M. Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug Discov. 5 (2006) 471-484
6. Suzuki K., et al. Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 2285-2290
7. Ishii K.J., et al. Genomic DNA released by dying cells induces the maturation of APCs. J. Immunol. 167 (2001) 2602-2607
8. Kawane K., et al. Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation. Nat. Immunol. 4 (2003) 138-144
9. Yasuda K., et al. Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways. J. Immunol. 174 (2005) 6129-6136
10. Okabe Y., et al. Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J. Exp. Med. 202 (2005) 1333-1339
11. Ishii K.J., et al. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 7 (2006) 40-48
12. Stetson D.B., and Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24 (2006) 93-103
13. Martin D.A., and Elkon K.B. Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll-like receptor 9-independent pathway. Arthritis Rheum. 54 (2006) 951-962
14. Shirota H., et al. Contribution of interferon-β to the immune activation induced by double-stranded DNA. Immunology 118 (2006) 302-310
15. Cortez-Gonzalez X., et al. TLR9-independent activation of B lymphocytes by bacterial DNA. DNA Cell Biol. 25 (2006) 253-261
16. Tokunaga T., et al. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J. Natl. Cancer Inst. 72 (1984) 955-962
17. Yamamoto S., et al. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity. J. Immunol. 148 (1992) 4072-4076
18. Krieg A.M., et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 (1995) 546-549
19. Hemmi H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
20. Hemmi H., et al. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J. Immunol. 170 (2003) 3059-3064
21. Kerkmann M., et al. Spontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-α induction by CpG-A in plasmacytoid dendritic cells. J. Biol. Chem. 280 (2005) 8086-8093
22. Sano K., et al. Oligodeoxynucleotides without CpG motifs work as adjuvant for the induction of Th2 differentiation in a sequence-independent manner. J. Immunol. 170 (2003) 2367-2373
23. Vollmer J., et al. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation. Immunology 113 (2004) 212-223
24. Roberts T.L., et al. Cutting edge: species-specific TLR9-mediated recognition of CpG and non-CpG phosphorothioate-modified oligonucleotides. J. Immunol. 174 (2005) 605-608
25. Kandimalla E.R., et al. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2′-deoxy-7-deazaguanosine motif as potent Toll-like receptor 9 agonists. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 6925-6930
26. Coban C., et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 201 (2005) 19-25
27. Choe J., et al. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 309 (2005) 581-585
28. Latz E., et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 5 (2004) 190-198
29. Cornelie S., et al. Direct evidence that toll-like receptor 9 (TLR9) functionally binds plasmid DNA by specific cytosine-phosphate-guanine motif recognition. J. Biol. Chem. 279 (2004) 15124-15129
30. Rutz M., et al. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur. J. Immunol. 34 (2004) 2541-2550
31. Ahmad-Nejad P., et al. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32 (2002) 1958-1968
32. Leifer C.A., et al. TLR9 is localized in the endoplasmic reticulum prior to stimulation. J. Immunol. 173 (2004) 1179-1183
33. Lindmo K., and Stenmark H. Regulation of membrane traffic by phosphoinositide 3-kinases. J. Cell Sci. 119 (2006) 605-614
34. Ishii K.J., et al. Potential role of phosphatidylinositol 3 kinase, rather than DNA-dependent protein kinase, in CpG DNA-induced immune activation. J. Exp. Med. 196 (2002) 269-274
35. Kuo C.C., et al. Class I and III phosphatidylinositol 3′-kinase play distinct roles in TLR signaling pathway. J. Immunol. 176 (2006) 5943-5949
36. Tabeta K., et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat. Immunol. 7 (2006) 156-164
37. Honda K., et al. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434 (2005) 1035-1040
38. Guiducci C., et al. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J. Exp. Med. 203 (2006) 1999-2008
39. Lakadamyali M., et al. Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes. Cell 124 (2006) 997-1009
40. Barton G.M., et al. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat. Immunol. 7 (2006) 49-56
41. Ishii K.J., et al. Manifold mechanisms of toll-like receptor-ligand recognition. J. Clin. Immunol. 25 (2005) 511-521
42. Boule M.W., et al. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J. Exp. Med. 199 (2004) 1631-1640
43. Means T.K., et al. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115 (2005) 407-417
44. Yasuda K., et al. CpG motif-independent activation of TLR9 upon endosomal translocation of 'natural' phosphodiester DNA. Eur. J. Immunol. 36 (2006) 431-436
45. Gursel M., et al. CXCL16 influences the nature and specificity of CpG-induced immune activation. J. Immunol. 177 (2006) 1575-1580
46. Bafica A., et al. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J. Exp. Med. 202 (2005) 1715-1724
47. Huang L.Y., et al. Th1-like cytokine induction by heat-killed Brucella abortus is dependent on triggering of TLR9. J. Immunol. 175 (2005) 3964-3970
48. Tabeta K., et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 3516-3521
49. Bave U., et al. FcγRIIa is expressed on natural IFN-α-producing cells (plasmacytoid dendritic cells) and is required for the IFN-α production induced by apoptotic cells combined with lupus IgG. J. Immunol. 171 (2003) 3296-3302
50. Blasius A.L., and Colonna M. Sampling and signaling in plasmacytoid dendritic cells: the potential roles of Siglec-H. Trends Immunol. 27 (2006) 255-260
51. Takeshita F., et al. Transcriptional regulation of the human TLR9 gene. J. Immunol. 173 (2004) 2552-2561
52. Guo Z., et al. A distal regulatory region is required for constitutive and IFN-β-induced expression of murine TLR9 gene. J. Immunol. 175 (2005) 7407-7418
53. Brummel R., et al. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice. Eur. J. Immunol. 36 (2006) 1951-1962
54. Uchijima M., et al. IFN-γ overcomes low responsiveness of myeloid dendritic cells to CpG DNA. Immunol. Cell Biol. 83 (2005) 92-95
55. Adachi Y., et al. IFN-γ primes RAW264 macrophages and human monocytes for enhanced oxidant production in response to CpG DNA via metabolic signaling: roles of TLR9 and myeloperoxidase trafficking. J. Immunol. 176 (2006) 5033-5040
56. Saikh K.U., et al. Human monocytes infected with Yersinia pestis express cell surface TLR9 and differentiate into dendritic cells. J. Immunol. 173 (2004) 7426-7434
57. Hayashi F., et al. Toll-like receptors stimulate human neutrophil function. Blood 102 (2003) 2660-2669
58. Jozsef L., et al. Activation of TLR-9 induces IL-8 secretion through peroxynitrite signaling in human neutrophils. J. Immunol. 176 (2006) 1195-1202
59. Miller L.S., et al. TGF-α regulates TLR expression and function on epidermal keratinocytes. J. Immunol. 174 (2005) 6137-6143
60. + dendritic cells protect against lethal Listeria monocytogenes infection. Eur. J. Immunol. 35 (2005) 2397-2405
61. Kuwajima S., et al. Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation. Nat. Immunol. 7 (2006) 740-746
62. Chan C.W., et al. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med. 12 (2006) 207-213
63. Pillarisetty V.G., et al. Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-γ via autocrine IL-12. J. Immunology 174 (2005) 2612-2618
64. Shen H., and Iwasaki A. A crucial role for plasmacytoid dendritic cells in antiviral protection by CpG ODN-based vaginal microbicide. J. Clin. Invest. 116 (2006) 2237-2243
65. Rotem Z., et al. Inhibition of virus multiplication by foreign nucleic acid. Nature 197 (1963) 564-566
66. Jensen K.E., et al. Interferon responses of chick embryo fibroblasts to nucleic acids and related compounds. Nature 200 (1963) 433-434
67. Napirei M., et al. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat. Genet. 25 (2000) 177-181
68. Yasutomo K., et al. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat. Genet. 28 (2001) 313-314
69. Morita M., et al. Gene-targeted mice lacking the Trex1 (DNase III) 3′ → 5′ DNA exonuclease develop inflammatory myocarditis. Mol. Cell. Biol. 24 (2004) 6719-6727
70. Yasuda K., et al. Macrophage activation by a DNA/cationic liposome complex requires endosomal acidification and TLR9-dependent and -independent pathways. J. Leukoc. Biol. 77 (2005) 71-79
71. Rifkin I.R., et al. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol. Rev. 204 (2005) 27-42
72. Sato S., et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6 (2005) 1087-1095
73. Yamamoto M., et al. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nat. Immunol. 7 (2006) 962-970
74. Naka T., et al. Negative regulation of cytokine and TLR signalings by SOCS and others. Adv. Immunol. 87 (2005) 61-122
75. Negishi H., et al. Negative regulation of Toll-like-receptor signaling by IRF-4. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 15989-15994
76. Takeshita F., et al. TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF. Eur. J. Immunol. 35 (2005) 2477-2485
77. Sugimoto K., et al. A serine/threonine kinase, Cot/Tpl2, modulates bacterial DNA-induced IL-12 production and Th cell differentiation. J. Clin. Invest. 114 (2004) 857-866
78. Kawai T., and Akira S. Innate immune recognition of viral infection. Nat. Immunol. 7 (2006) 131-137
79. Oganesyan G., et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439 (2006) 208-211
80. Hacker H., et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439 (2006) 204-207
81. Hoshino K., et al. IκB kinase-α is critical for interferon-α production induced by Toll-like receptors 7 and 9. Nature 440 (2006) 949-953
82. Kato H., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441 (2006) 101-105
83. Sun Q., et al. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24 (2006) 633-642
84. Kumar H., et al. Essential role of IPS-1 in innate immune responses against RNA viruses. J. Exp. Med. 203 (2006) 1795-1803
85. Igoucheva O., et al. Differential cellular responses to exogenous DNA in mammalian cells and its effect on oligonucleotide-directed gene modification. Gene Ther. 13 (2006) 266-275